Table: Kringle Pharma - 6-MTH parent results
May 14 (Reuters)-
Kringle Pharma, Inc.
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Mar 31, 2021 Mar 31, 2020 Sep 30, 2021
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 117 mln 206 mln
(-55.9 pct)
Operating loss 169 mln loss 1.04
Recurring loss 191 mln loss 1.02
Net loss 192 mln loss 1.02
EPS loss 48.33 yen loss 244.96 yen
Ann Div NIL NIL
-Q2 div NIL
-Q4 div NIL NIL
NOTE - Kringle Pharma, Inc..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4884.T